Effects of Regular Activity on Physiology Between Recreational Athletes of Different Body Fatness
Differences in Lipolysis, Circulating Hormones, and Muscle Quality Between Recreational Female Endurance Athletes of Different Body Sizes
1 other identifier
observational
15
1 country
1
Brief Summary
The popularity of marathons and endurance events has increased over the last few decades and, interestingly, the demographics of participants have also changed. From 1980 to 2002 the average race time to complete the marathon lengthened from \~3.5 hours to \~4.5 hours. Likewise, many endurance races include "Clydesdale" and "Athena" divisions for heavier weight male and female runners, respectively. As such, there has been an increase of overweight and obese participants in these races. For example, one study consisting of 250 runners determined, according to BMI, that approximately 15% and 31% of the female and male participants, respectively, were classified as overweight, with 31% and 33% classified as obese. Therefore, many recreational endurance athletes are overweight despite their high level of activity. On one hand, these data are positive as regular exercise reduces cardiovascular disease and all-cause mortality in overweight and obese populations. Yet, it is well documented in sedentary obese individuals that excess adiposity can lead to disturbances in adipocyte lipolysis and altered substrate utilization at rest and during exercise, and can decrease muscle quality. However, it is unknown if overweight individuals that exercise regularly have disrupted fat metabolism, circulating hormones, or muscle quality. No study has directly determined if differences exist in fat metabolism, circulating hormones, and muscle quality between overweight recreational female athletes and their lean counterparts when training status is equivalent. Therefore, the purpose of this investigation is to determine if differences in pre and post-exercise fat metabolism, circulating insulin and growth hormone, and muscle quality exist between active overweight individuals compared to active lean individuals with similar training history and who have regularly trained for and participated in endurance events within the last few years.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 23, 2020
CompletedFirst Submitted
Initial submission to the registry
January 26, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 16, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 7, 2021
CompletedFirst Posted
Study publicly available on registry
December 13, 2021
CompletedDecember 13, 2021
November 1, 2021
6 months
January 26, 2021
November 29, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Lipolysis
Tested via microdialysis. Two probe inserted into the subcutaneous abdominal adipose tissue to collect glycerol molecules (byproduct of lipolysis).
Second experimental visit for a total of 6 hours
Change in circulating insulin around an exercise bout
Insulin will be collected via blood draws. Blood will be drawn immediately following metabolic testing for resting measurements, immediately after the bout of physical activity, and every hour for 120 minutes' post activity.
Second experimental visit - Pre-exercise, Immediately post-exercise, and 120-minutes post-exercise
Change in circulating growth hormone around an exercise bout
Growth hormone Insulin will be collected via blood draws. Blood will be drawn immediately following
Second experimental visit - Pre-exercise, Immediately post-exercise, and 120-minutes post-exercise
Compositional Muscle Quality
Intramuscular fat accumulation percentage will be measured and estimated using B-mode ultrasound echo intensity via histogram analysis and composition equations
First experimental visit - 15 minutes
Functional Muscle Quality
Functional MQ is measured via force production (via Biodex) divided muscle size (via dual energy X-ray absorptiometry).
First experimental visit - 30 minutes
Secondary Outcomes (1)
Blood Sampling Analysis
Second experimental visit - Pre-exercise, immediately after the resting metabolic measurements
Study Arms (2)
Normal body fat cohort
Determining the general amount of lipolysis, circulating insulin and growth hormone, and muscle quality of a group of recreational female endurance athletes with normal body fat determined by air displacement plethysmograph.
Excess body fat cohort
Determining the general amount of lipolysis, circulating insulin and growth hormone, and muscle quality of a group of recreational female endurance athletes with excess body fat determined by air displacement plethysmograph.
Eligibility Criteria
Fourteen active female endurance athletes (8 lower body fat, 6 higher body fat) will be recruited to participate in this study
You may qualify if:
- Female participants will be recruited for the study
- (BMI of \<29.9 kg/m2).
- Ages of 18 and 45 years old
- Weight stable (± 2 kg) for the last three months
- Regularly endurance training on most days of the week for at least one hour for the last two years
- Participants will be eumenorrheic and premenopausal
You may not qualify if:
- Resting blood pressure above 160 mmHg systolic or 100 mmHg diastolic
- Type 1 or type 2 diabetes; 3)
- Other medical problems in which exercise is contraindicated
- chronic infections
- Diagnoses, signs, or symptoms of cardiovascular disease
- Respiratory disease
- Musculoskeletal disease
- Musculoskeletal injuries in the last six months that would prevent them from engaging in endurance training.
- Pregnant or lactating and must have a
- Irregular menstrual cycle
- Smoking
- Diagnosed eating disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institute of Sports Science and Medicine, Florida State University
Tallahassee, Florida, 32306, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle Investigator
Study Record Dates
First Submitted
January 26, 2021
First Posted
December 13, 2021
Study Start
October 23, 2020
Primary Completion
April 16, 2021
Study Completion
June 7, 2021
Last Updated
December 13, 2021
Record last verified: 2021-11